Tibsovo is an inhibitor of the isocitrate dehydrogenase 1 (IDH1) enzyme, and healthcare professionals recommend this medication to treat patients with acute myeloid leukemia (AML) and cholangiocarcinoma. Tibsovo is supplied in the form of tablets in 250 mg strength for oral administration. This medicine is available from multiple pharmaceutical suppliers in India, and Tibsovo cost is reasonable. To know more about this drug, contact Indian Pharma Network.